RecruitingNCT06405009

Prediction Model of Occult Omental Metastasis in Patients With Gastric Cancer

A Nomogram for Predicting Occult Omental Metastasis in Patients With Gastric Cancer


Sponsor

Northern Jiangsu People's Hospital

Enrollment

450 participants

Start Date

Apr 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

A complete omentectomy is typically recommended during radical total gastrectomy for gastric cancer, though its impact on survival remains unclear. This study aimed to assess the frequency and risk factors of metastases in the greater omentum in gastric cancer patients undergoing gastrectomy. It will involve a single prospective cohort of consecutive patients who underwent total gastrectomy with complete en bloc omentectomy and modified D2 lymphadenectomy. Post-surgery, the omentum will dissect from the gastrectomy specimen beyond the gastroepiploic vessels and examine separately for pathological assessment. The primary outcome will focus on the detection of omental metastases.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria5

  • pathological confirmation of gastric cancer
  • eligibility for surgical intervention
  • undergoing first rectal cancer surgery
  • acquisition of written informed consent from patients and their families
  • no history of hypertrophic scar or allergic predispositions

Exclusion Criteria4

  • absence of postoperative pathology of the omentum
  • diagnosis of multiple primary malignancies
  • intraoperative discovery of widespread implant metastases within the abdominal cavity
  • severe comorbidities

Interventions

OTHERWithout any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors

Without any intervention, we only divided gastric cancer patients into two groups based on postoperative pathology, and analyzed their basic characteristics and risk factors


Locations(1)

Yifan Cheng

Yangzhou, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06405009


Related Trials